Luís Costa

27PUBLICATIONS
113CO-AUTHORS
Cancer diagnosisPredictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Apr 27, 2026
Differentiating Upper Tract Urothelial Carcinoma with Synchronous or Metachronous Bladder Cancer.

|Feb 26, 2026
Assessing the Impact of Comprehensive Genomic Profiling on Therapeutic Selection for Advanced Solid Tumors in Portugal.

Nuno Tavares, Pedro Simões, Raquel Lopes-Brás

|Nov 08, 2025
Risk Factors for Disease Recurrence in Patients with HER2+ Early Breast Cancer and Implications for Therapy: A Narrative Review.

Marina E Cazzaniga, Luis Costa, Gilles Freyer

|Oct 13, 2025
Succinate Dehydrogenase B (SDHB) Overexpression with Enzymatic Dysfunction Defines a Distinct Subtype of Undifferentiated Pleomorphic Sarcoma.

Miguel Esperança-Martins, Hugo Vasques, Manuel Sokolov Ravasqueira

|Jul 14, 2025
Immunodiagnostic plasma amino acid residue biomarkers detect cancer early and predict treatment response.

Cong Tang, Patrícia Corredeira, Sandra Casimiro

|May 30, 2025
RANK Pathway Inhibition Sensitizes Triple-Negative Breast Cancer to CDK4/6 Inhibitors and Enhances Immune Response.

Inês Gomes, Maria Martelo, Rúben D Vilela

Pageof 5

Frequent Collaborators

10 joint publications

Sandra Casimiro

6 joint publications

Marta Martins

5 joint publications

André Mansinho

5 joint publications

Catarina Abreu